GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
4,997
Funds Holding Change
+60
Funds Holding Growth
+1%
Value
$1.4T
Holding in Top 10
963
Top 10 Change
+113
Top 10 Growth
+13%
Value Growth
+9%
New
253
Increased
2,413
Reduced
1,972
Closed
128
Capital Inflow
$40.4B
Capital Outflow
$31.8B
Net Capital Flow
+$8.61B
Capital Flow Change
+$5.36B
Calls
$19.4B
Puts
$21.6B
Net Calls
-$2.21B
Put/Call Ratio
1.11